Prospects of Levetiracetam as a Neuroprotective Drug against Status Epilepticus, Traumatic Brain Injury and Stroke
Levetiracetam (LEV) is an antiepileptic drug commonly used for the treatment of partial onset and generalized seizures. In addition to its neuromodulatory and neuroinhibitory effects via its binding to the synaptic vesicle protein SV2A, multiple studies have suggested neuroprotective properties for...
Main Author: | Ashok K Shetty |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2013-11-01
|
Series: | Frontiers in Neurology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fneur.2013.00172/full |
Similar Items
-
Levetiracetam versus phenytoin in children with status epilepticus
by: Gowhar Wani, et al.
Published: (2019-01-01) -
Mechanisms of levetiracetam in the control of status epilepticus and epilepsy
by: Laxmikant S Deshpande, et al.
Published: (2014-01-01) -
Intravenous levetiracetam versus phenobarbital in children with status epilepticus or acute repetitive seizures
by: Yun-Jeong Lee, et al.
Published: (2016-01-01) -
Review of Levetiracetam as a First Line Treatment in Status Epilepticus in the Adult Patients- What do we know so far?
by: Robin eDavis, et al.
Published: (2013-08-01) -
Emergency treatment with levetiracetam or phenytoin in status epilepticus in children—the EcLiPSE study: study protocol for a randomised controlled trial
by: Mark D. Lyttle, et al.
Published: (2017-06-01)